Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.
Eur J Med Chem
; 202: 112525, 2020 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-32634628
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Triazoles
/
Nuclear Proteins
/
Herpesviridae Infections
/
Herpesvirus 8, Human
/
Isoquinolines
Type of study:
Risk_factors_studies
Language:
En
Journal:
Eur J Med Chem
Year:
2020
Document type:
Article